Orthopaedics

MagnetOs™ Bone Graft FloraSeal® SurgiSeal® Zip Skin Closure ADAPTABLE® RAMP™ Leg Positioner Cast21 Fracture Casting Medtronic RF Ablation Aquamantys™ PlasmaBlade™ RadiaLux™ MatriDerm® Dermal Matrix Negative Pressure Wound Therapy Q-Close™ Sutures

MagnetOs™ is a bone graft like no other: thanks to its NeedleGrip™ surface technology, it grows bone even in soft tissues.* This surface technology provides traction for our body’s vitally important ‘pro-healing’ immune cells (M2 macrophages).†‡ [1,2] 

This in turn, unlocks previously untapped potential to stimulate stem cells – and form new bone throughout the graft.†§[3-6] 

MagnetOS Bone Graft

1. Duan, et al. eCM. 2019;37:60-73.
2. Van Dijk, et al. eCM. 2021;41:756-73.

3. Van Dijk, et al. JOR Spine. 2018;e1039. 
4. Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6):2080-2090. 
5. Van Dijk, et al. Clin Spine Surg. 2020;33(6):E276-E287. 
6. Data on file. 

5. Van Dijk, et al. Clin Spine Surg. 2020;33(6):E276-E287.
6. Data on file.

2. Van Dijk, et al. eCM. 2021;41:756-73.
6. Data on file.

2. Van Dijk, et al. eCM. 2021;41:756-73.
3. Van Dijk, et al. JOR Spine. 2018;e1039.
4. Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6):2080-2090.
5. Van Dijk, et al. Clin Spine Surg. 2020;33(6):E276-E287.

6. Data on file.
12. Yu, et al. J Cell Biochem. 2016;117(7):1511-1521.
13. Ligouri, et al. Cell Mol Immunol. 2021;18(3):711-722.

6. Data on file.
13. Ligouri, et al. Cell Mol Immunol. 2021;18(3):711-722.
14. Zhang, et al. Cell Tissue Res. 2017.
15. Arosarena, et al. J Cell Physiol. 2011;226(11):2943-2952.

6. Data on file.
13. Ligouri, et al. Cell Mol Immunol. 2021;18(3):711-722.

The growing body of science behind NeedleGrip is called osteoimmunology. But for surgeons and their patients it means one thing: a more predictable fusion.†¶[5,6] 

MagnetOs is proven to be equivalent to the gold standard of autograft for spinal fusions.[2,4,5,16]  It has been used in more than 25,000 fusion surgeries to date and is supported by an unprecedented blend of scientific, pre-clinical and clinical studies through Project Fusion: our global research program, where science and clinical evidence meet.

Kuros is dedicated to reliably translate evidence from benchtop through to patient. To see how, review our extensive list of studies including peer-reviewed results from our latest Level I clinical trial published in Spine.[16]

2. Van Dijk, et al. eCM. 2021;41:756-73.
4. Van Dijk, et al. J Biomed Mater Res. Part B: Appl Biomater. 2019;107(6):2080-2090.
5. Van Dijk, et al. Clin Spine Surg. 2020;33(6):E276-E287.
16. Stempels, et al. Spine. 2024;49(19):1323-1331.

16. Stempels, et al. Spine. 2024;49(19):1323-1331.

  • Surgical Site Infections (SSI) have been shown to increase Arthroplasty costs by 61%[1] and it is estimated that 2% to 5% of all patients who undergo surgery will develop a SSI.[2]
  • The median cost of treating Prosthetic Joint Infection is $34,800 per patient[3] with infection shown as the cause of 17% of Revision Hips and 24.1% of Revision Knees[4]
FloraSeal®
  • FloraSeal has been shown to trap and immobilise bacteria that may cause infection to the patient. It rapidly and powerfully kills gram-positive and gram-negative bacteria.[5]
  • FloraSeal effectively reduces microbial colonisation within 15 minutes and maintains a low microbial colonisation throughout the 24 hours after application, has the same efficacy when being used with or without an antimicrobial surgical incise drape, and mitigates microorganisms more effectively than an antimicrobial surgical incise drape alone.[6]

1. Peel, T.N., Cheng, A.C., Liew, D., Buising, K.L., Lisik, J., Carroll, K.A., Choong, P.F.M. and Dowsey, M.M. (2015), Direct Hospital Cost Determinants Following Hip and Knee Arthroplasty. Arthritis Care & Research, 67: 782-790. https://doi.org/10.1002/acr.22523

2. Towfigh, S., Cheadle, W. G., Lowry, S. F., Malangoni, M. A., & Wilson, S. E. (2008). Significant reduction in incidence of wound contamination by skin flora through use of microbial sealant. Archives of surgery (Chicago, Ill.:1960), 143(9), 885–891.

3. Peel, T. N., Cheng, A. C., Lorenzo, Y. P., Kong, D. C., Buising, K. L., & Choong, P. F. (2013). Factors influencing the cost of prosthetic joint infection treatment. The Journal of hospital infection, 85(3), 213–219. https://doi.org/10.1016/j.jhin.2013.07.012

5. Prince, D., Kohan, K., Solanki, Z., Mastej, J., Prince, D., Varughese, R., & Patel, M. (2017). Immobilization and death of bacteria by Flora Seal microbial sealant. Int J Pharm Sci Invent, 6(6), 45-49.

6. Data on File. HB Fuller - Medical Adhesives Technology

SurgiSeal® Topical Skin Adhesive is a high purity, antimicrobial, liquid topical skin adhesive that can replace sutures for incision or laceration repair.

SurgiSeal® is the only topical skin adhesive in the world to receive FDA 510K Clearance in demonstrating inhibition of gram-positive and gram-negative bacteria growth.[1]

SurgiSeal® provides the optimal balance between strength and flexibility. In replacing sutures for incision or laceration repair, it can save time, provide a flexible, water-resistant, protective coating, and eliminate the need for suture removal.

FloraSeal®

1. SurgiSeal IFU: Due to the anhydrous property of the SurgiSeal adhesive, gram+ and gram- bacteria which become incorporated within the adhesive upon application, are not expected to grow.

Zip is a non-invasive skin closure device for surgical incisions and lacerations. It's designed to distribute strain along the incision. This helps reduce wound complications[1,2], saving you cost and time.[3,5]

Zip’s benefits aren’t only limited to healthcare providers. The puncture-free skin closure method also leads to greater patient satisfaction.[6] This means less pain, a greater range of motion during recovery, and reduced scarring.[7,8]

Q-Close™ surgical suturesAustralian Distributor

1. Carli A., Haas SB. Novel Non-Invasive Secure Skin Closure Following Total Knee Arthroplasty: Fewer Wound Complications & No Patient Home Care Visits Compares to Staples, Paper presented at ISTA; 1 Oct 2015; Vienna, Austria.
2. Davis, A., et. al., Effect of Surgical Incision Closure Device on Skin Perfusion Following Total Ankle Arthoplasty, UF Health Poster Presentation at ACFAS, March 2017

1. Carli A., Haas SB. Novel Non-Invasive Secure Skin Closure Following Total Knee Arthroplasty: Fewer Wound Complications & No Patient Home Care Visits Compares to Staples, Paper presented at ISTA; 1 Oct 2015; Vienna, Austria.

3. Alnachoukati O, Emerson R, Muraguri M (March 20,2019) Non-Invasive, Zip Type Skin Closure Device vs. Conventional Staples in Total Knee Arthroplasty: Which Method Holds Greater Potential for Bundled Payments?. Cures 11(3):e4281. DOI 10.7759/cureus.4281

3. Alnachoukati O, Emerson R, Muraguri M (March 20,2019) Non-Invasive, Zip Type Skin Closure Device vs. Conventional Staples in Total Knee Arthroplasty: Which Method Holds Greater Potential for Bundled Payments?. Cures 11(3):e4281. DOI 10.7759/cureus.4281
5. Goldman DS, Hammill E, Aasbo J, Storne E, Reddy S. Improvement in S-ICD Incision Closure Time and High Implanter Satisfaction Using a Novel Skin Closure Device. Scientific presentation given at Asia-Pacific Heart Rhythm Society 2017 Meeting; Sep 16, 2017; Yokohama, Japan.

4. Tanaka, Y. et al. Randomized Study of a New Noninvasive Skin Closure Device for Use After Congenital Heart Operations. Ann Thorac Surg 2016.

5. Goldman DS, Hammill E, Aasbo J, Storne E, Reddy S. Improvement in S-ICD Incision Closure Time and High Implanter Satisfaction Using a Novel Skin Closure Device. Scientific presentation given at Asia-Pacific Heart Rhythm Society 2017 Meeting; Sep 16, 2017; Yokohama, Japan.

6. Menkowitz B, Olivieri G, Belson O (January 19, 2020) Patient Satisfaction and Cosmetic Outcome in a Randomized, Prospective Study of Total Knee Arthroplasty Skin Closure Comparing Zip Surgical Skin Closure with Staples. Cureus 12(1): e6705. DOI 10.7759/cureus.6705

7. Alnachoukati O, Emerson R, Muraguri M (March 20,2019) Non-Invasive, Zip Type Skin Closure Device vs. Conventional Staples in Total Knee Arthroplasty: Which Method Holds Greater Potential for Bundled Payments?. Cures 11(3):e4281. DOI 10.7759/cureus.4281
8. Benner RW, Behrens JP. Poster Presentation: “A Novel Skin Closure Device for (Bilateral) Total Knee Arthroplasty: Randomized Controlled Trial vs. Staples.” Poster Presentation presented at American Association of Hip and Knee Surgeons; Nov 3, 2017;

8. Benner RW, Behrens JP. Poster Presentation: “A Novel Skin Closure Device for (Bilateral) Total Knee Arthroplasty: Randomized Controlled Trial vs. Staples.” Poster Presentation presented at American Association of Hip and Knee Surgeons; Nov 3, 2017;

9. Levi K, Ichiryu K, Kefel P, et al. (October 12, 2016) Mechanics of Wound Closure: Emerging Tape-Based Wound Closure Technology vs. Traditional Methods. Cureus 8(10); e827. DOI 10.7759/cureus.827

10. Ko, J. H., Yang, I. H., Ko, M. S., Kamolhuja, E. and Park, K. K. (2016), Do zip-type skin-closing devices show better wound status compared to conventional staple devices in total knee arthroplasty?. Int Wound J, 14: 250-254. doi:10.1111/iwj.12596

4x

faster

than sutures[5]

12x

stronger

than sutures[9]

2x

better

cosmetic appearance[4]

ADAPTABLE® is the first fully-sterile, surgeon-controlled limb and retractor holder. The fully-mechanical carbon fibre surgical arm works seamlessly with any standard operating table and has the ability to reduce the number of assistants in the operating room. ADAPTABLE is easy to set up, transport, and store.

ADAPTABLE Limb and Retractor Holder - Australian distributor

Introducing the RAMP™ Knee Positioning System is a cutting-edge medical device designed to elevate the standard of care in surgical environments. Built for precision, speed, and safety, RAMP optimizes retraction and procedural access, enabling surgeons to work more efficiently with enhanced visibility and control.

RAMP™ Knee Positioning System

  • Six Stable Positions
    Effortlessly transition between approximately 55°, 90°, 115°, 140°, and 150° knee flexion angles, facilitating unrestricted soft tissue assessment and seamless dynamic registration for computer navigation.

  • Enhanced Surgical Ergonomics
    The elevated foot design minimizes changes in the surgical field's height during procedures, promoting better ergonomics and reducing strain.

  • Optimized Pad Design
    Features a firm, flat surface for stable foot positioning and a soft, rounded distal side to protect the Achilles tendon, ensuring patient comfort throughout the procedure.

  • Simple Setup
    Quickly secures to any standard operating room table using two Velcro straps, streamlining setup and turnover times.

  • Hands-Free Stability
    When used with a lateral support and a wedge beneath the hip, the RAMP provides maximum stability across all six leg positions, allowing unobstructed access to the surgical site.

Cast21 is a long-overdue upgrade to traditional fracture immobilization. Designed with both patients and providers in mind, Cast21 offers a faster, cleaner, and more comfortable alternative to plaster and fiberglass casts.

Cast21 orthopaedic casting fracture immobilization Australian Distributor

  • Rapid application
    Quick to apply, with no lengthy wait times.

  • Mess-free
    Eliminates plaster and fiberglass dust, water, and debris.

  • Breathable and waterproof
    Improves hygiene, reduces odor, and allows normal showering/swimming.

  • Lightweight open-lattice design
    Increases airflow and comfort while maintaining strength.

  • Improved patient experience
    Less skin irritation and more freedom in daily activities.

  • Durable and supportive
    Ensures reliable immobilization without the bulk of traditional casts.

  • Faster return to life
    Helps patients get back to work, sport, and daily routines sooner.

The Accurian™ Radiofrequency Ablation (RFA) platform combines proprietary hardware design and quad core processing, resulting in sophisticated algorithms that manage power and control temperature during ablation surgery. The Accurian™ Radiofrequency Ablation (RFA) therapy platform has been extensively tested for lasting reliability and is upgrade-ready for the future.

Accurian™

Internally cooled probes create larger, spherical lesions (compared to standard lesions) with greater distal projection.

  • Larger spherical lesions (compared with standard lesions)
  • Flexibility in approach angle with enhanced probes: as much as 45% of lesion volume is projected distally to probe tip

Internally cooled probes create larger, spherical lesions

PROCEDURES

  • Knee OA/Pain
  • Hip OA/Pain
  • Shoulder OA/Pain
Accurian™ in knee procedures
  • Shown to reduce blood loss by 40% in THA and decrease transfusions by 73%[7]
  • Improves maintenance of haemoglobin levels compared to traditional electrosurgery[7,8]
  • Reduces post-operative drainage compared to traditional electrosurgery[8]
  • Reduces transfusion rates[7,8,9]
  • Reduces length of stay following THA[9]
Aquamantys™
  • Increases the percentage of patients discharged home after THA[9,10]
  • Has been shown to reduce the incidence of haematoma, one of the top three reasons for TJA readmission, by 75% in THA[8,9]
  • Has been shown to reduce post-operative pain and swelling leading to a reduced incidence of hemarthrosis following TKA[11]
  • Has been shown to reduce operative time during infected THA revisions[12]

PROCEDURES

  • Total knee arthroplasty
  • Total hip arthroplasty
  • Total shoulder arthroplasty
  • Revision orthopaedic surgery
  • Amputation
  • Trauma

7. Marulanda GA,Ulrich SD, Seyler TM, Delanois RE, Mont MA. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008;5(2):125–131.

7. Marulanda GA,Ulrich SD, Seyler TM, Delanois RE, Mont MA. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008;5(2):125–131.
8. Suarez JC, Slotkin EM, Szubski CR, Barsoum WK, Patel PD. Prospective, Randomized Trial to Evaluate Efficacy of a Bipolar Sealer in Direct Anterior Approach Total Hip Arthroplasty. J Arthroplasty 2015;30(11):1953–8.

8. Suarez JC, Slotkin EM, Szubski CR, Barsoum WK, Patel PD. Prospective, Randomized Trial to Evaluate Efficacy of a Bipolar Sealer in Direct Anterior Approach Total Hip Arthroplasty. J Arthroplasty 2015;30(11):1953–8.

7. Marulanda GA,Ulrich SD, Seyler TM, Delanois RE, Mont MA. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices. 2008;5(2):125–131.
8. Suarez JC, Slotkin EM, Szubski CR, Barsoum WK, Patel PD. Prospective, Randomized Trial to Evaluate Efficacy of a Bipolar Sealer in Direct Anterior Approach Total Hip Arthroplasty. J Arthroplasty 2015;30(11):1953–8.
9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.

9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.

9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.
10. Nichols C, Vose J. Clinical Outcomes and Costs Within 90 days of Primary or Revision Total Joint Arthroplasty. Arthroplasty 2016;Epub ahead of print.

8. Suarez JC, Slotkin EM, Szubski CR, Barsoum WK, Patel PD. Prospective, Randomized Trial to Evaluate Efficacy of a Bipolar Sealer in Direct Anterior Approach Total Hip Arthroplasty. J Arthroplasty 2015;30(11):1953–8.
9. Ackerman SJ, Tapia CI, Baik R, Pivec R, Mont MA. Use of a Bipolar Sealer in Total Hip Arthroplasty: Medical Resource Use and Costs Using a Hospital Administrative Database. Orthopedics 2014;37(5):e472–481.

11. Rosenberg AG. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthroplasty 2007;22(4 Suppl 1):82–85.

12. Clement RC, Derman PB, Graham DS, Speck RM, Flynn DN, Levin LS, Fleisher LA. Risk factors, causes, and the economic implications of unplanned readmissions following total hip arthroplasty. J Arthroplasty. 2013 Sep;28(8 Suppl):7-10.

  • Single skin-to-skin instrument eliminates device exchanges, and as a result, the risk of scalpel injuries incurred during exchanges[13,14]
  • Compared to scalpel and traditional electrosurgery, the PlasmaBlade™ has demonstrated a 12% reduction in operative time during total knee arthroplasty[13]
  • Comparable blood loss to scalpel and traditional electrosurgery,[13] with reduced thermal injury compared to traditional electrosurgery[15]
PlasmaBlade™

PROCEDURES

  • Total knee arthroplasty
  • Total hip arthroplasty
  • Total shoulder arthroplasty
  • Patients with pacemaker, DBS, or spine stimulator insitu

13. Data on file. VR-00083 study summary. 71-10-2454.
14. Vose JG, McAdara-Berkowitz J. Reducing scalpel injuries in the operating room. AORN J. 2009;90(6):867-872.

13. Data on file. VR-00083 study summary. 71-10-2454.

15. Ruidiaz ME, Messmer D, Atmodjo DY, et al. Comparative healing of human cutaneous surgical incisions created by the PEAK PlasmaBlade, conventional electrosurgery, and a standard scalpel. Plast Reconstr Surg. 2011;128(1):104-111.

  • The RadiaLux™ lighted retractor is a single-use retractor designed to provide surgeons with the ability to manipulate soft tissue through a combination of blades when assembled onto a retractor handle.
  • The retractor provides illumination to the surgical field independent of an external light source or fibre optic cables.
  • The lighted retractor is indicated for enhancing visibility to a surgical field through retraction of soft tissue and illumination of the surgical cavity.
RadiaLux™

MatriDerm® works as a regenerative adhesion barrier for both tendons and nerves.

MatriDerm® provides an optimal protective environment during tendon healing and avoids adhesion formation.

  • Protects tendons from the formation of fibrin deposits and fibrin bridges
  • Allows the passage of cytokines, growth factors and nutrients necessary for optimal tendon healing
  • Allows for the intrinsic healing process to be completed without scar formation or adhesions
  • Provides an optimal protective environment
  • Guides structured healing
  • Remodels and results in excellent functional outcome
MatriDerm® works as a regenerative adhesion barrier for both tendons and nerves.

According to a recent review, application of a single-use negative pressure wound therapy system reduced the rate of SSI by 58% compared to standard of care. Additionally, patients had less hospital LOS compared to standard of care.[1]

RadiaLux™

The Genadyne NPWT portfolio is completely comprehensive, from Ultraportable Single-Use and Reusable Pumps to High Demand and Instil Pumps. The Dressing Portfolio is compatible across all NPWT Pumps, allowing for an all-inclusive ecosystem for a hospital institution. From Absorbent Dressings that can be used with or without NPWT, ready to use Foam Dressings, and all the way to large Foam Kits, Abdominal Kits and PVA Kits.

Closed incision management negative pressure has been proven to:

  • Protect the incision from external contamination
  • Hold closed incision wound edges together
  • Help reduce tensile forces across the incision
  • Help reduce oedema
  • Reduce seroma and haematoma fluid collection
  • Suitable for dehisced wounds, trauma wounds, partial thickness burns, flaps and grafts

Green Foam

More than just a colour…

The visual impact of the Genadyne Green Foam is undeniable. Green was chosen to allow clinicians to better differentiate between viable and nonviable tissue in the wound bed. The colour contrast increases differentiation with the wound bed.

RadiaLux™

Competitor

RadiaLux™

Patented Genadyne Green Foam

  • Genadyne Green Foam is a fully reticulated polyurethane foam made with polyether resin to allow better hydrolytic stability. The design increases performance under pressure and in moist environments.
  • The Dodecahedron cell structure gives a three-dimensional skeletal strand to the cells providing enhanced filtering qualities and increasing the removal of exudate and infectious materials. This cell structure also increases tensile strength to prevent fraying. Fraying is significantly reduced, preventing stray pieces from being left in the wound bed.
  • The combination of cell structure and composition gives the foam a non-adherent property, allowing for easier removal during dressing changes, thereby reducing pain and discomfort.
  • The foam creates direct contact with the wound bed, allowing for even distribution of pressure. This assists in reducing oedema and promotes tissue perfusion and granulation.

Properties

Benefits

Fully reticulated polyurethane foam

Increased hydrolytic stability

Polyether resin

Increased tensile strength

Pore Size

Boosts performance under pressure

Dodecahedron cell structure / 3 dimensional skeletal strands

Enhanced filtering qualities
Increased tensile strength
Reduced risk of fraying
Non-adherent properties
Reduced discomfort during dressing change

Variable Pressure

The advanced variable pressure capabilities of all of the Genadyne Negative Pressure Pumps, allow different negative pressures to be used without the downsides of painful intermittent therapy.

By maintaining negative pressure throughout the cycle, variable negative pressure wound therapy avoids losing an airtight seal and displacement of the dressing. This gradual “wave” is gentler to the patient increasing blood flow to the peri-wound and preventing ischemia. The changes in pressure are imperceptible to the patient, increasing patient comfort and compliance.

The literature suggests that the use of Variable Pressure is beneficial. It results in decreased blood flow that is known to stimulate angiogenesis and granulation tissue formation and to increase blood flow that is known to facilitate oxygenation and nutrient supply and removal of waste products. [2]

Cycling the negative pressure level may be beneficial especially when treating poorly vascularized tissue with a risk for development of ischemia, as pressure is released repeatedly.[2]

Image

1. Sugrue M, Ciprandi G, Djohan R, et al. . World Union of Wound Healing Societies (WUWHS) Consensus Document. Closed surgical incision management: Understanding the role of NPWT. Wounds Int [Internet]. 2016. www.woundsinternational.com/wuwhs/view/consensus-document-closed-surgica... (Last accessed July 29, 2017)

2. Ola Borgquist, MD; Richard Ingemansson, MD, PhD; and Malin Malmsjö, MD, PhD (2010) The Effect of Intermittent and Variable Negative Pressure Wound Therapy on Wound Edge Microvascular Blood Flow

Q-Close™ surgical sutures deliver the precision, reliability, and consistency surgeons expect—without the premium price tag.

Q-Close™ surgical suturesAustralian Distributor

Manufactured by Healthium Medtech, the world’s largest independent producer of surgical needles and one of the top global suture suppliers, Q-Close™ brings world-class quality to the Australian market.

Our range includes absorbable and non-absorbable options in a variety of sizes, materials, and needle configurations—engineered for optimal tissue handling, knot security, and minimal trauma. Backed by decades of surgical expertise and rigorous manufacturing standards, Q-Close™ gives you confidence in every closure.

Revolution Surgical Pty Ltd
4/22 Rowood Road, Prospect NSW 2148
ABN: 63 165 643 434

© 2018- Revolution Surgical

Website by: WebInjection